CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 US Application 17/696,249Filed on 2022-03-16
Compositions And Methods For Modulation Of LMNA Expression Read more about Compositions And Methods For Modulation Of LMNA Expression US Application 17/277,397Filed on 2021-03-18
TEM8 Antibodies and Their Use Read more about TEM8 Antibodies and Their Use Australia2019253864Filed on 2019-10-24
Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging Read more about Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging Sweden19711727.8Filed on 2019-02-15
Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging Read more about Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging The Netherlands19711727.8Filed on 2019-02-15
Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging Read more about Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging United Kingdom19711727.8Filed on 2019-02-15
Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging Read more about Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging France19711727.8Filed on 2019-02-15
Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging Read more about Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging Germany19711727.8Filed on 2019-02-15
Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging Read more about Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging Switzerland19711727.8Filed on 2019-02-15
LIQUID BIOPSY TO DETECT CANCER EARLY AND SENSITIVELY IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 Read more about LIQUID BIOPSY TO DETECT CANCER EARLY AND SENSITIVELY IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 US Application 17/586,676Filed on 2022-01-27